Completed PHASE1 INTERVENTIONAL 4-arm NCT01543529

A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers

A Single Center, Randomized, Double-blind, Single-dose, Four Period, Crossover Study to Investigate Pharmacodynamics and Pharmacokinetics of RO4917838 Alone or With Concomitant Administration of Alcohol in Healthy Volunteers

Sponsor: Hoffmann-La Roche

Conditions Healthy Volunteer

Interventions Alcohol Placebo to RO4917838 RO4917838

Updated 6 times since 2017 Last updated: May 9, 2017 Started: Feb 28, 2012 Primary completion: Jun 4, 2012 Completion: Jun 4, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01543529, this PHASE1 trial focuses on Healthy Volunteer and remains completed. Sponsored by Hoffmann-La Roche, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jun 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Completed PHASE1

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hoffmann-La Roche

Data source: Hoffmann-La Roche

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rennes, France